More interestingly, we found an anti-inflammatory effect of CIRP agonist zr17-2 in vivo as evidenced by the reduction in the numbers of macrophage infiltration and the levels of inflammatory cytokine in the MI heart. Here, CIRBP is linked to myocardial infarction.